188 related articles for article (PubMed ID: 12050585)
1. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.
Batres LA; Mamula P; Baldassano RN
J Pediatr Gastroenterol Nutr; 2002 May; 34(5):558-60. PubMed ID: 12050585
[No Abstract] [Full Text] [Related]
2. Dermatologic manifestations of Crohn disease in children: response to infliximab.
Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for peristomal pyoderma gangrenosum.
Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
Cocco A; Angelucci E; Viscido A; Caprilli R
Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
[No Abstract] [Full Text] [Related]
5. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease.
Teich N
Tech Coloproctol; 2014 Oct; 18(10):965-6. PubMed ID: 24965074
[No Abstract] [Full Text] [Related]
6. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
7. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
Sapienza MS; Cohen S; Dimarino AJ
Dig Dis Sci; 2004 Sep; 49(9):1454-7. PubMed ID: 15481318
[TBL] [Abstract][Full Text] [Related]
9. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
Nybaek H; Jemec GB
Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
[No Abstract] [Full Text] [Related]
10. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
[TBL] [Abstract][Full Text] [Related]
11. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum and tumor necrosis factor α agents.
Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
[No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.
Ljung T; Staun M; Grove O; Fausa O; Vatn MH; Hellström PM
Scand J Gastroenterol; 2002 Sep; 37(9):1108-10. PubMed ID: 12374238
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
Alkhouri N; Hupertz V; Mahajan L
Inflamm Bowel Dis; 2009 Jun; 15(6):803-6. PubMed ID: 18942748
[No Abstract] [Full Text] [Related]
15. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
[TBL] [Abstract][Full Text] [Related]
16. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
Tanczos BT; Baumgart DC
Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
[No Abstract] [Full Text] [Related]
17. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
18. [Infliximab for a girl with refractory pyoderma gangrenosum].
Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.
Ariane M; Bouaziz JD; de Masson A; Jachiet M; Bagot M; Lepelletier C
Dermatol Ther; 2019 Jan; 32(1):e12774. PubMed ID: 30341800
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]